Kexing Biopharm Co., Ltd.SSE: 688136

Announcement on the Progress of Proposed Transfer of Equity of Wholly-owned Subsidiary

Jul 3, 2025 · Issued by Kexing Biopharm Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Jul 3, 2025

On 6ix: 6ix.com/news/announcement-on-the-progress-of-proposed-transfer-of-equity-of-wholly-owned-subsidiary

Announcement on the Progress of Proposed Transfer of Equity of Wholly-owned Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Kexing Biopharm Co., Ltd. on 6ix

Earlier from Kexing Biopharm

Indicative Announcement on Change in Shareholder and Persons Acting in Concert's Equity Reaching an Integer Multiple of 5%Jul 1, 2025
Kexing Biopharm's GB18 project received clearance of IND application from NMPA and FDAMay 28, 2025

Later from Kexing Biopharm

Announcement on Abnormal Fluctuations in Stock TradingJul 4, 2025
Kexing Biopharm Makes Its Debut at CPHI 2025, Followed by the 2025 International Pharmaceutical Cooperation High-End Forum, One of the Kexing Biopharm's Series of Globalization Activities in ShanghaiJul 4, 2025
Announcement on Shareholding Changes Reaching 1% Threshold, Completion of Shareholding Reduction Plan and Results of Shares SoldJul 10, 2025
Announcement on Vesting Results and Share Listing in the 1st Vesting Period of the 2024 Restricted Stock Incentive PlanJul 11, 2025
Announcement on General Election of Board of DirectorsJul 29, 2025

All Kexing Biopharm news releases

Follow Kexing Biopharm into a list and get an email when it puts out news.

Follow Kexing Biopharm